Biomanufacturing for food and pharma
Can the future of food production and pharmaceutical development shift into sustainable biofactories? From bespoke molecules and advanced therapeutics to engineered tissues and new materials, bioreactors are becoming the manufacturing engines of the future. This session highlights breakthrough platforms, business models, and regulatory pathways that could allow bio-based production to scale while reducing environmental footprints.
Speakers
Ian Roberts, CTO, Buhler Group
Deniz Kent, Co-founder & CEO, Prolific Machines
Michelle Ruiz, CEO & Founder, Hyfé
Johannes le Coutre, Professor Food & Health, University of New South Wales, Sydney
Ryan Heath, Host of AI Leadership Lab, AI Leadership Lab